Public preview. Funding rounds, founders, and growth signals require a free account.

Aradigm

Aradigm is a cell and gene therapy company that has created a financial and delivery model to improve access to these treatments by addressing pricing, infrastructure, and outcomes across payers, providers, manufacturers, and patients. The company aims to standardize costs and ensure sustainable coverage for therapies that can treat previously untreatable diseases but have historically carried prohibitive price tags.

Health11-50 employees

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Aradigm on FlareSight

Get notified the moment Aradigm files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.